Hospital News and Research

RSS

Shuyusan-containing serum protects SH-SY5Y cells against corticosterone-induced impairment

Synthetic antidepressants present a narrow spectrum and side effects following long-term application. Recently, medical practitioners have shown interest in the use of Chinese medicines for the treatment of diseases and in the adjustment of the human response to stress.

7 Sep 2013

Penn’s ITMAT symposium addresses topics of direct relevance to translational science

The Institute for Translational Medicine and Therapeutics' 7th Annual International Symposium (ITMAT) symposium, Harnessing the Paradox: Personalization and the Science of Scale, to be held in October 2013, will address topics of direct relevance to translational science.

7 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

D&A PHARMA, a leading company in the Addiction therapeutic area, announces today its strong participation in the 14th Congress of European Company of Biomedical Search on the Alcoholism (ESBRA), which will be held in Warsaw from September 8th to 11th.

7 Sep 2013

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

FUJIFILM SonoSite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced CE mark approval for its newest generation of point-of-care ultrasound: the X-Porte Ultrasound Kiosk.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

Abraxane drug gets FDA approval for patients with advanced pancreatic cancer

The U.S. Food and Drug Administration today approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by Scottsdale Healthcare and the Translational Genomics Research Institute.

7 Sep 2013

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

The Saban Research Institute recently hosted the 3rd annual Meaningful Use of Complex Medical Data (MUCMD) Symposium. Organized by Randall Wetzel, MD, chairman of the Department of Anesthesiology and Critical Care Medicine at Children's Hospital Los Angeles, MUCMD is a forum that fosters communication between physicians and "Big Data" experts in order to make use of the large amounts of medical data.

7 Sep 2013

ARRO recognizes 56 educators with 2013 ARRO Educator of the Year Award

The Association for Residents in Radiation Oncology (ARRO) has recognized 56 educators with the 2013 ARRO Educator of the Year Award.

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

Newly joined nursing students receive $2,500 grant from Capella University

As part of its ongoing effort to make higher education more affordable, Capella University, a regionally accredited online university* that has built its reputation by providing high quality online degree programs for working adults, is offering a $2,500 grant opportunity for new nursing students who enroll in eligible Bachelor of Science in Nursing (BSN), Masters of Science in Nursing (MSN), or Doctorate of Nursing (DNP) programs.

7 Sep 2013

Basic fibroblast growth factor can protect endplate in motor neurons of injured spinal cord

In current studies, the degeneration and protection measures in the distal end of the injured spinal cord and target organ muscle effector have scarcely been investigated. The distal end of the spinal cord and neuromuscular junction may develop secondary degenera-tion and damage following spinal cord injury because of the loss of neural connections.

7 Sep 2013

Safety and health checklist to help kids avoid emergency room

With the school year underway, Children's Hospital Los Angeles experts have developed a safety and health checklist to help kids avoid the emergency room and develop productive extracurricular and learning activities to enhance the classroom experience. What do parents need to consider? Many symptoms of childhood conditions are often discovered in the classroom.

7 Sep 2013

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.

7 Sep 2013

Plasma marker inflames schizophrenia risk

Elevated plasma levels of the inflammatory molecule C-reactive protein may be a marker of an increased risk for developing schizophrenia, a study suggests.

6 Sep 2013

Exercise may not be ‘one size fits all’ in bipolar patients

Researchers say that more study is needed of the relationship between exercise and symptoms among patients with bipolar disorder.

6 Sep 2013

Muscle atrophy therapy: an interview with Dr. Levine, Clinical Associate Professor at Temple University School of Medicine

Atrophy is loss of muscle which can occur in response to either pain or trauma. When you stop using something like muscle it gets weaker.

6 Sep 2013

Cellular Biomedicine Group reports interim results of Phase I/IIa clinical trial for Knee Osteoarthritis

Cellular Biomedicine Group, Inc. today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis, which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.

6 Sep 2013

Locus coeruleus plays major role in learning, memory and other cognitive functions

Death of neurons in the dorsal raphe nucleus and locus coeruleus is a pathological characteristic of the disease. Previous studies concerning the pathological characteristic of Alzheimer's disease mainly focus on learning and memory-related hippocampus, and less attention has been paid to the locus coeruleus.

6 Sep 2013

Non-adherent bone marrow cell-derived mesenchymal stem cells could differentiate into neuronal-like cells

It is widely believed that bone marrow mesenchymal stem cells are highly adherent fibroblastic cells, defined as colony-forming unit-fibroblasts. Nevertheless, a few reports have shown that the non-adherent bone marrow cells can give rise to colony-forming unit-fibroblasts in vitro, and possess a certain differentiation potential.

6 Sep 2013

Hospital News and Research

Shuyusan-containing serum protects SH-SY5Y cells against corticosterone-induced impairment

Penn’s ITMAT symposium addresses topics of direct relevance to translational science

Research roundup: The financial burden of hospital acquired infections

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Abraxane drug gets FDA approval for patients with advanced pancreatic cancer

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

ARRO recognizes 56 educators with 2013 ARRO Educator of the Year Award

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Newly joined nursing students receive $2,500 grant from Capella University

Basic fibroblast growth factor can protect endplate in motor neurons of injured spinal cord

Safety and health checklist to help kids avoid emergency room

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Plasma marker inflames schizophrenia risk

Exercise may not be ‘one size fits all’ in bipolar patients

Muscle atrophy therapy: an interview with Dr. Levine, Clinical Associate Professor at Temple University School of Medicine

Cellular Biomedicine Group reports interim results of Phase I/IIa clinical trial for Knee Osteoarthritis

Locus coeruleus plays major role in learning, memory and other cognitive functions

Non-adherent bone marrow cell-derived mesenchymal stem cells could differentiate into neuronal-like cells

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News